Last update :
17/04/2024
Antiviral   Ganciclovir sodium  
Injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References Pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Ceptyl Mexico
Ciganclor Argentina
Citovirax Italy
Cymevan France
Cymeven Germany
Cymevene Australia, Austria, Belgium, Brazil, Chile, Colombia, Croatia, Denmark, Ecuador, Egypt, Finland, Great Britain, Greece, Hungary, Iceland, Iran, Ireland, Italy, Luxembourg, Malaysia, Mexico, Netherlands, New Zealand, Norway, Peru, Poland, Portugal, Russian, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, Venezuela
Cymevir Brazil
Cytovene Canada, United States of America
Ganciclovir Argentina, Canada, Chile, Ecuador, France, Germany, Mexico, United States of America
Gavir India
Inglav Mexico
Natclovir India
Pharcigave Mexico
Umecortil Colombia, Mexico
Viraprex Mexico
Stability in solutions   Injection   Stability in solutions : Ganciclovir sodium     
Container Solvent Concentration Temperature Storage Duration of stability References
Glass Sodium chloride 0,9% 20 mg/ml -8°C Not specified
24 Day
3796
Level of evidence C

Glass Sodium chloride 0,9% 20 mg/ml 25°C Not specified
24 Day
3796
Level of evidence C

Glass Sodium chloride 0,9% 20 mg/ml 5°C Not specified
24 Day
3796
Level of evidence C

Polyvinyl chloride NaCl 0,9% or Glucose 5% 1 & 5 mg/ml 25°C Not specified
35 Day
76
Level of evidence C

Polyvinyl chloride NaCl 0,9% or Glucose 5% 1 & 5 mg/ml 5°C Protect from light
35 Day
76
Level of evidence C

Polyvinyl chloride NaCl 0,9% or Glucose 5% 2.5 mg/ml 25°C Protect from light
5 Day
69
Level of evidence D

Polyvinyl chloride NaCl 0,9% or Glucose 5% 2.5 mg/ml 4°C Protect from light
5 Day
69
Level of evidence D

Polyvinyl chloride Sodium chloride 0,9% 0,28 & 1,4 mg/ml -20°C Protect from light
365 Day
245
Level of evidence B

Polyvinyl chloride Sodium chloride 0,9% 0,28 & 1,4 mg/ml 25°C Not specified
8 Day
245
Level of evidence B

Polyvinyl chloride Sodium chloride 0,9% 0,28 & 1,4 mg/ml 4°C Protect from light
80 Day
245
Level of evidence B

Polyvinyl chloride Glucose 5% 1 >> 2,5 mg/ml 4°C Protect from light
240 Day
4
Level of evidence D

Polyvinyl chloride Glucose 5% 1,5 & 10 mg/ml 4-8°C Protect from light
35 Day
70
Level of evidence B+

Polyvinyl chloride Glucose 5% 5 & 10 mg/ml -20°C Protect from light
28 Day
88
Level of evidence C

Polyvinyl chloride Glucose 5% 5 & 10 mg/ml 4°C Protect from light
28 Day
88
Level of evidence C

Polypropylene Sodium chloride 0,9% 0,25 mg/ml 2-8°C Protect from light
185 Day
4021
Level of evidence A

Polypropylene Sodium chloride 0,9% 0,25 mg/ml 23-27°C Protect from light
185 Day
4021
Level of evidence A

Polypropylene Sodium chloride 0,9% 5 mg/ml 2-8°C Protect from light
185 Day
4021
Level of evidence A

Polypropylene Sodium chloride 0,9% 5 mg/ml 23-27°C Protect from light
185 Day
4021
Level of evidence A

Polypropylen Syringe Sodium chloride 0,9% 1,4 & 7 mg/ml -20°C Protect from light
365 Day
245
Level of evidence B

Polypropylen Syringe Sodium chloride 0,9% 1,4 & 7 mg/ml 25°C Not specified
8 Day
245
Level of evidence B

Polypropylen Syringe Sodium chloride 0,9% 1,4 & 7 mg/ml 4°C Protect from light
80 Day
245
Level of evidence B

Polypropylen Syringe Sodium chloride 0,9% 5 mg/ml 2-8°C Protect from light
185 Day
4021
Level of evidence A

Polypropylen Syringe Sodium chloride 0,9% 5 mg/ml 23-27°C Protect from light
185 Day
4021
Level of evidence A

Polypropylen Syringe Sodium chloride 0,9% 5,8 mg/ml 25°C Light
12 Hour
74
Level of evidence B

Polypropylen Syringe Sodium chloride 0,9% 5,8 mg/ml 4°C Protect from light
10 Day
74
Level of evidence B

Polyisoprene elastomer NaCl 0,9% or Glucose 5% 1 & 6 mg/ml 25°C Not specified
24 Hour
604
Manufacturer's stability data

Polyisoprene elastomer NaCl 0,9% or Glucose 5% 1 & 6 mg/ml 4°C Protect from light
15 Day
604
Manufacturer's stability data


  Mentions Légales